Low molecular weight heparin does not prevent VTE after knee arthroscopy, studies show
BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i6549 (Published 06 December 2016) Cite this as: BMJ 2016;355:i6549- Susan Mayor
- London
Prophylactic treatment with low molecular weight heparin (LMWH) does not prevent symptomatic venous thromboembolism (VTE) in patients who undergo knee arthroscopy or have a leg immobilised in plaster, two randomised studies have shown.1
Patients who have undergone arthroscopic knee surgery and those who have their lower leg in plaster are at increased risk of VTE. Thromboprophylaxis is well established in other types of orthopaedic procedures, including hip and knee replacement surgery, because it reduces the risk of thrombosis while only …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.